Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?-Reference-Cited by-同舟云学术

Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?

Published:2020-07-22 Issue:10 Volume:59 Page:1217-1236
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Bukkems Vera E.,Colbers Angela^ORCID,Marzolini Catia,Molto Jose,Burger David M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-020-00914-x.pdf

Reference125 articles.

1. DHHS. Recommendations for the use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States. https://aidsinfo.nih.gov/guidelines/html/3/perinatal/0 ]. Accessed 20 Feb 2020.

2. Smith PF, DiCenzo R, Morse GD. Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors. Clin Pharmacokinet. 2001;40(12):893–905.

3. Malaty LI, Kuper JJ. Drug interactions of HIV protease inhibitors. Drug Saf. 1999;20(2):147–69.

4. US FDA. Rifadin: label 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050420s083,050627s025lbl.pdf . Accessed 5 May 2020.

5. EMA. Stocrin: summary of product characteristics. 2014. https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000250/WC500058946.pdf . Accessed 5 May 2020.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBPK Modeling of Lamotrigine and Efavirenz during Pregnancy: Implications for Personalized Dosing and Drug-Drug Interaction Management;Pharmaceutics;2024-09-03

2. Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics;Vaccines;2024-07-16

3. Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa;Journal of Antimicrobial Chemotherapy;2024-07-13

4. A study on the fine management mode of obstetric pregnancy drugs under the payment of disease diagnosis-related groups (DRG);2024-04-30

5. Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential;Expert Review of Anti-infective Therapy;2024-03-27